November 17, 2017 5:00 PM ET


Company Overview of Xellia Pharmaceuticals AS

Key Executives for Xellia Pharmaceuticals AS

NameBoard RelationshipsTitleAge
Carl-Åke Carlsson No RelationshipsChief Executive Officer and President54
Mads Bodenhoff No RelationshipsChief Financial Officer and Vice President--
Rajeev Khurana No RelationshipsManaging Director of India--
Monica Hagen No RelationshipsHead of Production for Oslo and Operations Director of Oslo--
Attila Mile No RelationshipsHead of Production for Budapest and General Manager of Budapest--
View More Key Executives

Xellia Pharmaceuticals AS Board Members*

NameBoard RelationshipsPrimary CompanyAge
Steen Riisgaard 60 RelationshipsALK-Abelló A/S66
George E. Griffin 12 RelationshipsXellia Pharmaceuticals AS--
Benny Dalgaard Loft 30 RelationshipsØrsted A/S52
Andreas Rummelt Ph.D. 37 RelationshipsInterPharmaLink AG61
Per Valstorp 49 RelationshipsALK-Abelló A/S68
View All Board Members

Xellia Pharmaceuticals AS Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board George E. Griffin12 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Xellia Pharmaceuticals AS CEO Compensation
Industry Average


Realm Therapeutics plc Announces Executive Changes
November 17, 2017 7:00 AM ET
SCYNEXIS Appoints Scott Sukenick as General Counsel
November 16, 2017 10:56 PM ET
Viridium Pacific Group Ltd. Announces Executive Changes
November 16, 2017 6:01 PM ET
Index Pharmaceuticals Holding AB (publ) Announces Appointments to Nomination Committee
November 16, 2017 3:00 PM ET
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Executive Changes
November 16, 2017 2:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xellia Pharmaceuticals AS, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at